Who is sponsoring NCT05509517?

NCT05509517 is sponsored by Universitaire Ziekenhuizen KU Leuven.

What condition does NCT05509517 study?

NCT05509517 studies Atrial Fibrillation and Flutter, Atrial Fibrillation, Postoperative Complications, Arrhythmia.

Is NCT05509517 still recruiting?

NCT05509517 is currently completed. Last updated 30 November 2023.

Last reviewed 2023-11-30 · How we verify

NCT05509517: SURGICAL-AF 2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Trial of the Use of Remote Heart Rhythm Monitoring With a Smartphone After Cardiac Surgery

Completed NA Last updated 30 November 2023

What this trial tests

NA trial testing Photoplethysmography based smartphone application for heart rhythm analysis (FibriCheck™) in Atrial Fibrillation and Flutter in 450 participants. Completed in 4 September 2023.

Timeline

2 November 2021

Primary endpoint
5 July 2023

4 September 2023

Quick facts

Lead sponsor	Universitaire Ziekenhuizen KU Leuven
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	450
Start date	2 November 2021
Primary completion	5 July 2023
Estimated completion	4 September 2023
Sites	1 location across Belgium

Drugs / interventions tested

Photoplethysmography based smartphone application for heart rhythm analysis (FibriCheck™)

Conditions studied

Atrial Fibrillation and Flutter — all drugs for Atrial Fibrillation and Flutter →
Atrial Fibrillation — all drugs for Atrial Fibrillation →
Postoperative Complications — all drugs for Postoperative Complications →
Arrhythmia — all drugs for Arrhythmia →

Sponsor

Universitaire Ziekenhuizen KU Leuven — full company profile →

Who can join

18 and older, any sex, with Atrial Fibrillation and Flutter or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to evaluate the clinical consequences following the detection of postoperative atrial fibrillation or flutter (POAF) using a remote heart rhythm monitoring strategy with a photoplethysmography based smartphone technology in the early postoperative period after discharge.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Improving atrial fibrillation or flutter detection and management by smartphone-based photoplethysmography rhythm monitoring following cardiac surgery: a pragmatic randomized trial.
Gruwez H, De Melio N, Vermunicht P, Van Langenhoven L, et al · · 2025 · cited 2× · PMID 39823508 · DOI 10.1093/europace/euaf015

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation and Flutter

Currently open trials in the same condition.

NCT06187155 — Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients · NA · recruiting

Other Universitaire Ziekenhuizen KU Leuven trials

Trials by the same sponsor.

NCT06831955 — LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer · Phase 2 · recruiting
NCT07356505 — Efficacy and Safety of Micra AV2 Transcatheter Pacing System · NA · recruiting
NCT07286968 — Gastro-Intestinal Digestion and Physiology After Bariatric Surgery · recruiting
NCT06962137 — Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer · Phase 2 · recruiting
NCT07270536 — Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05509517 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitaire Ziekenhuizen KU Leuven
Last refreshed: 30 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing